HMN-176, an Active Metabolite of the Synthetic Antitumor Agent HMN-214, Restores Chemosensitivity to Multidrug-Resistant Cells by Targeting the Transcription Factor NF-Y

Hideki Tanaka, Nobuko Ohshima, Mami Ikenoya, Kinuyo Komori, Fumitaka Katoh, Hiroyoshi Hidaka

Research output: Contribution to journalArticlepeer-review

69 Citations (Scopus)

Fingerprint

Dive into the research topics of 'HMN-176, an Active Metabolite of the Synthetic Antitumor Agent HMN-214, Restores Chemosensitivity to Multidrug-Resistant Cells by Targeting the Transcription Factor NF-Y'. Together they form a unique fingerprint.

Medicine & Life Sciences